cancer breakthrough pain
Pain · 2007–2014
3decisions
2medicines
0carried consumer input
0individual submissions
No submission for this condition has carried consumer input, including the 2 made since the comments facility came into use.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| fentanyl Management of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy and are unable to tolerate further escalation of… | Mar 2014 | Not recommended | unclear |
| fentanyl Management of breakthrough pain in patients with cancer who are already receiving maintenance opioid therapy for chronic pain and are unable to tolerate… | Mar 2014 | Not recommended | unclear |
| fentanyl citrate Treatment of breakthrough pain in palliative care patients with cancer who are receiving opioids for their persistent cancer pain where further escalation in… | Nov 2007 | Recommended with restriction | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 2 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.